-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on WAVE Life Sciences, Lowers Price Target to $22

Benzinga·07/31/2026 15:42:12
Listen to the news
B. Riley Securities analyst Madison El-Saadi maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $31 to $22.